Disorders
By
Prof. Abdulqader Alhaider
Definition
of Affected Disorders
Either Depresion or mania
Incidence: Depression is a chronic and
recurrent illness that can affect at
least 20% of the population at some
period in their lifetime. An estimated
35-40 million Americans living today
will suffer from major Depressive
Illness during their lives.
only.
Symptoms of Depression
The symptoms of Depressive Illness are highly
recognizable, both to those affected and to those
closest to them, once they are told what to look for.
Here is a checklist of symptoms of Depressive
illness:
Loss of energy and interest.
Diminished ability to enjoy oneself.
Decreased -- or increased -- sleeping or appetite.
Difficulty in concentrating; indecisiveness; slowed
or fuzzy thinking.
Exaggerated feelings of sadness, hopelessness, or
anxiety.
Feelings of worthlessness.
Recurring thoughts about death and suicide.
If most of these symptoms last for two weeks or
more, you probably have Depressive Illness.
Sometimes depression alternates with "mania"
and is called Manic-Depressive Illness
(Bipolar).
Symptoms of Mania
causes
NE
NE
Mania
Rx Drugs that decrease NE
Depression
Drugs that increase NE
What
Classification of Antidepressants
Based on Site of Action (see Fig 29-2)
A ) Drugs that Block the RE-uptake of NE and 5HT ( e.g.:Most tricyclics)
B)
Sedation Why?
Cardiovascular effects (Tachycardia and hypotension) How?
Anticholinergic effects
Weight gain.
Seizure
Hypomania
5-HT reuptake
Noradrenaline
reuptake
5-HT2 antagonism
Tricyclic antidepressants
Amitriptyline
Clomipramine
Desipramine
Dothiepin
Doxepin
Imiprmine
Lofipramine
Nortriptyline
+ +
+
?
+
+
-
+
++
+
+
+
+
+
+
?
+
+
Amitriptyline
Amoxapine
Clomipramine
Desipramine
Dothiepin
Doxepin
Imipramine
Lofepramine
Nortriptyline
Protriptyline
Trimipramine
Sedation
Cardiotoxicity
+++
++
++
+
+++
+++
++
+
+
+++
+++
+
+++
+++
+++
++
+++
+
++
+++
+++
Reuptake inhibition
Hypotension
+++
+
++
+
++
++
+++
+
0/+
+
++
AntiCholinnergic
+++
++
++
++
++
++
+++
+
++
++
++
NE
++
+++
+/++++
+
+
+
++++
+++
++++
+
5-HT
+++
+
+++
+/+
+
+++
+
+
+
+
Pharmacokinetics:
+
+
+
+
+
Noradrenaline
reuptake
5-HT2
antagonists
Citalopram
Fluoxetine
Fluvoxamine
Paroxetine
Sertraline
Cardiotoxicty
?
_
_
_
Nausea
++
++
+++
++
++
Anticholinergic
effects
_
_
_
+
_
Sedation
_
_
+
+
_
2 adrenoceptors antagonists
e.g. Mirtazepine (Romeron ); Mianserin
act by increasing the release of 5-HT and NE
Via
Differ from SSIR in
Increase appetite (good for patients taking
cancer chemotherapy) NO N/V why? No
Sexual dysfunction Why ? ; sedation. Also,
produces constipation and rarely leads to
agranulocytosis
Venlavaxine (EffexorR): Act by blocking 5HT and NE uptake but it has side effects
profile similar to SSRI. However, it may
produce seizure and constipation. Why?
Amoxapine
Buproprion
Maprotiline
Mianserin
Nafazodone
Nomifensine
Trazodone
Venlafaxine
5-Ht reuptake
Noradrenaline
reuptake
5-HT2 antagonism
-/+
++
+
+
+
+
+
+
+
+
+
-
Mianserin
Mirtazepine
Nefazodone
Trazodone
Venlafaxine
Toxicity
+
+
Sedation
++
++
+
+++
++
Hypotension
+
+++
-
Anticholinergic
effects
+
+
+
Classifications of MAOIs
Either:
Hydralazine Derivatives (Phenelzine (Nardil)
Non hydralazine DER.(Tranylcypramine (Parnate)
appetite
Drug
Non-selective
irreversible
Selective
reversible
Sedation
Anticholinergic Hypotensin
effects
Isocarboxazid
++
Phenelzine
++
Tranylcypromine
Moclobemide
Premature ejaculation
G.
H.
Anxiety disorders
Migraine
Nocturnal Enuresis in children e.g. Imipramine
I.
LITHIUM :
MOA : Remember its similarity to sodium thus
it:
inhibits the release of NE
- Increases re-uptake of NE
- Decreases second messenger in
postsynaptic neurons (decrease c-AMP; IP3
and DAG))
Side effects
1) Endocrine side effects
-
Clinical Uses:
Plasma level :
Drug interactions:
Why
What
Why?
Lithium
and pregnancy?
Moderate to severe
intoxication
(Lithium level 2.0-2.5 mEq /l)
Gatrointestinal:
Anorexia nervosa
Persistent nausea and vomiting
Neurological :
Blurred vision
Muscle fasciculations
Clonic limb movements
Hyperactive deep tendon reflexes
Choreoathetoid movements
convulsions
Delirium
Syncope
Electroencephalographic changes
Stuper
Coma